Authors: Lew, A Chamberlin, AR

Citation: A. Lew et Ar. Chamberlin, Human T-cell Kv1.3 potassium channel blockers: new strategies for immunosuppression, EXPERT OP T, 10(6), 2000, pp. 905-915

Authors: Bridges, RJ Kavanaugh, MP Chamberlin, AR

Citation: Rj. Bridges et al., A pharmacological review of competitive inhibitors and substrates of high-affinity, sodium-dependent glutamate transport in the central nervous system, CUR PHARM D, 5(5), 1999, pp. 363-379

Authors: Lew, A Chamberlin, AR

Citation: A. Lew et Ar. Chamberlin, Blockers of human T cell Kv1.3 potassium channels using de novo ligand design and solid-phase parallel combinatorial chemistry, BIOORG MED, 9(23), 1999, pp. 3267-3272

Authors: Gilmore, MA Steward, LE Chamberlin, AR

Citation: Ma. Gilmore et al., Incorporation of noncoded amino acids by in vitro protein biosynthesis, T CURR CHEM, 202, 1999, pp. 77-99

Authors: Koch, HP Kavanaugh, MP Esslinger, CS Zerangue, N Humphrey, JM Amara, SG Chamberlin, AR Bridges, RJ

Citation: Hp. Koch et al., Differentiation of substrate and nonsubstrate inhibitors of the high-affinity, sodium-dependent glutamate transporters, MOLEC PHARM, 56(6), 1999, pp. 1095-1104

Authors: Koch, HP Chamberlin, AR Bridges, RJ

Citation: Hp. Koch et al., Nontransportable inhibitors attenuate reversal of glutamate uptake in synaptosomes following a metabolic insult, MOLEC PHARM, 55(6), 1999, pp. 1044-1048